Post-drilling analysis delivers positive results for 88 Energy

|

Published 25-JUN-2021 09:57 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

With the oil price continuing to hit multi-year highs and the S&P/ASX 200 Energy Index (ASX:XEJ) hovering in the vicinity of 8200 points, up nearly 70% from its COVID crash low of about 5000 points last March, it may be time to look at some of the smaller players in the energy sector that have been overlooked despite surges in the majors such as Woodside Petroleum (ASX:WPL), Santos (ASX:STO) and Oil Search (ASX:OSH).

On this note, 88 Energy (ASX:88E; AIM:88E; OTC:EEENF) may be worth considering, particularly following recent developments that have seen a new managing director take the helm, a cash injection of US$18.7 million that has extinguished its debt and today’s release of results from the group’s Merlin-1 testing program.

Investors appear to have latched onto these developments this week with the company’s shares increasing 25%.

Along with some other highly prospective assets, Merlin-1 is on the North Slope of Alaska.

The Merlin-1 well was spudded in March 2021 and targeted 645 million barrels of gross mean prospective resource.

Drilling is now complete, and interpretation of results is underway.

A second well, Harrier-1, is planned to be drilled in 2022 and is targeting a gross mean prospective resource of 417 million barrels.

Geochemical analysis of Merlin-1 fluids yields positive results

88 Energy has recently received initial results from 5 of the 18 specifically selected trims from the side wall cores, with 2 of the 5 confirming the presence of hydrocarbons.

Importantly, these depths were among the prospective zones that were not able to be tested with the RDT downhole fluid extraction tool.

These zones also correspond with depths where good oil shows were noted during drilling - in geological terms, this included petroliferous odour, fluorescence and cut.

Small trims were cut from the side of several of the 48 side wall cores to undergo special analysis, and the remaining material is reserved for routine core analysis.

The following gas chromatography charts show a spread of carbon compounds with lighter molecules on the left and heavier components on the right.

As illustrated above, oil signatures may be inferred by the presence of heavier carbon compounds seen in two of the five samples run to date.

Importantly these signatures show no evidence of biodegradation, and the highly encouraging test results to date serve to refine the company’s understanding of both the quantity and the mobility of hydrocarbons in place as well as the commercial potential of the greater Project Peregrine acreage, which will be further appraised in coming seasons.

Project Peregrine is located in the NPR-A region of the North Slope of Alaska and encompasses approximately 195,000 contiguous acres.

As shown below, it is situated on-trend to recent discoveries in a newly successful play type in topset sands in the Nanushuk formation.

More in-depth analysis to inform future exploration

Management flagged the pending release of further results from the remaining 13 trims over the coming weeks, and in discussing these recent developments said, “The company is highly encouraged by the preliminary results received to date from the Merlin-1 testing program, with analysis and interpretation of results ongoing.

"Once complete, these will be consolidated and integrated into the Project Peregrine database, which will form the basis of future farm-out and exploration on the acreage.’’

Phase two of the geochemical analysis program on the side-wall core trims will commence after completion of the analysis of the remaining 13 trims, which will include a range of analytical processes.

The following graphic highlights the comprehensive nature of analysis completed to date (blue) and work that is still to be completed (grey).



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X